1. Collette L, Sylvester RJ, Stenning SP, et al. Impact of the treating institution on survival of patients with “poor-prognosis” metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party. J Natl Cancer Inst 1999;91(10):839–846.
2. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975–2000. Bethesda: National Cancer Institute, 2003.
3. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(suppl 8):S4–S66.
4. Brown LM. Testis. In: Harras A (ed) Cancer: Rates and Risks. Bethesda: National Cancer Institute, 1996:194–196.
5. Bernstein L, Smith MA, Liu L, et al. Germ cell, trophoblastic and other gonadal neoplasms. In: Ries LAG, et al. (eds). Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995 (NIH Pub. No. 99-4649). Bethesda, MD: National Cancer Institute, 1999.